X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 45 filers reported holding X4 PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $477,544 | -43.8% | 438,114 | 0.0% | 0.00% | – |
| Q2 2023 | $849,941 | +23.4% | 438,114 | +446.9% | 0.00% | – |
| Q1 2021 | $689,000 | +27.4% | 80,113 | -4.9% | 0.00% | – |
| Q4 2020 | $541,000 | -3.7% | 84,237 | +1.4% | 0.00% | – |
| Q3 2020 | $562,000 | -27.1% | 83,096 | +0.5% | 0.00% | – |
| Q2 2020 | $771,000 | +75.6% | 82,693 | +88.5% | 0.00% | – |
| Q1 2020 | $439,000 | +27.6% | 43,864 | +36.3% | 0.00% | – |
| Q4 2019 | $344,000 | -15.9% | 32,187 | 0.0% | 0.00% | – |
| Q3 2019 | $409,000 | +131.1% | 32,187 | +172.5% | 0.00% | – |
| Q2 2019 | $177,000 | – | 11,810 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 311,490 | $532,000 | 1.65% |
| Bain Capital Life Sciences Investors, LLC | 6,389,436 | $10,926,000 | 1.30% |
| Tri Locum Partners LP | 2,504,006 | $4,282,000 | 1.18% |
| Sio Capital Management, LLC | 1,418,461 | $2,426,000 | 0.77% |
| NEA Management Company, LLC | 6,523,157 | $11,155,000 | 0.56% |
| AIGH Capital Management LLC | 997,719 | $1,706,000 | 0.53% |
| Parkman Healthcare Partners LLC | 950,000 | $1,625,000 | 0.46% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $573,000 | 0.34% |
| Worth Venture Partners, LLC | 250,144 | $428,000 | 0.26% |
| Ikarian Capital, LLC | 568,612 | $973,000 | 0.19% |